The Human Microbiome Project milestone announced
On Jun. 13, 2012, the Human Microbiome Project announced the completion of a seminal study of microbial diversity….
Biotechnology | Disease | FDA | Oncology | Therapeutics | Women's Health
Genentech drug Perjeta (pertuzumab) was approved
On Jun. 8, 2012, the U.S. Food and Drug Administration (FDA) announced that Genentech’s drug Perjeta (pertuzumab) was…
Scientists decoded genome of Chagas disease
On Jun. 5, 2012, an international team of scientists decoded genome of Chagas disease. Previously, scientists had only…
First patent application granted for CRISPR-Cas9 gene editing in all environments
On May 25, 2012, Drs. Jennifer Doudna, Emanulle Charpentier, Martin Jinek of UC Berkeley and Krzystof Chylinski of…
The U.S. Senate declared May 16, 2012 as Hereditary Angioedema Awareness Day (HAE)
ON May 16, 2012, the U.S. Senate unanimously passed a resolution (S. Res. 286) recognizing May 16, 2012,…
Biotechnology | Disease | FDA | Therapeutics
FDA approved orphan drug Elelyso to treat a form of Gaucher disease
On May 1, 2012, the U.S. Food and Drug Administration (FDA) approved new orphan drug Elelyso to treat…
Treatment outcomes in black and white children with cancer was published
On Apr. 30, 2012, “Treatment Outcomes in Black and White Children With Cancer: Results From the SEER Database…
Siemens introduced Eclipse, an ultra discreet completely-in-the-canal hearing instrument
On Mar. 29, 2012, Siemens, now Sivantos, introduced Eclipse , an ultra discreet completely-in-the-canal hearing instrument. The history…
Biotechnology | CDC | Oncology | Therapeutics
Report to the nation finds continuing declines in cancer death rates since the early 1990s
On Mar. 29, 2012, the U.S. Centers for Disease Control and Prevention (CDC) reported that death rates from…
OHSU’s Oregon National Primate Research Center opened dedicated lab space
On Mar. 27, 2012, the Oregon National Primate Research Center at OHSU dedicated a new home for its…
The Priestley Medal was awarded to Robert S. Langer
On Mar. 27, 2012, the American Chemical Society awarded the Priestley Medal to Robert S. Langer “to recognize…
Single antibody shrinks variety of human tumors transplanted into mice, study showed
On Mar. 26, 2012, researchers at Stanford University School of Medicine reported study results that showed human tumors…
University of Washington Medical Center becomes first in PNW to discharge Total Artificial Heart patient
On Mar. 21, 2012, the University of Washington Medical Center became the first in Pacific Northwest to discharge…
Biotechnology | Diagnostics | Disease | Genomics | NIH | Therapeutics
Draft sequence of the gorilla genome was published
On Mar. 8, 2012, an international team led by researchers at the Wellcome Trust Sanger Institute announced they…
OHSU-led consortium awarded $21 million grant to study alcoholism, stress
On Mar. 8, 2012, the National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a five-year, $21 million…
Duke Cancer Institute opened the Duke Cancer Center, a new 7-floor building
On Feb. 27, 2012, the Duke Cancer Institute opened a new 267,000-square-foot, $235 million Cancer Center that included…
Mice bred to more closely resemble a genetic variation in humans help target an annual outbreak: the flu
On Feb. 21, 2012, as part of a national collaboration, Oregon Health & Science University researchers were studying…
Biotechnology | Disease | FDA | Therapeutics
The FDA approved Korlym for patients with endogenous Cushing’s syndrome
On Feb. 17, 2012, the FDA announced Korlym (mifepristone) was approved to control high blood sugar levels (hyperglycemia)…
The FDA approved Gleevec for Five Rare, Life-Threatening Disorders
On Jan. 31, 2012, the U.S. Food and Drug Administration (FDA) granted Gleevec (imatinib) regular approval for use…
The FDA approved KALYDECO (ivacaftor) a University of Washington-tested drug to treat the genetic mechanism of cystic fibrosis
On Jan. 31, 2012, the FDA approved a KALYDECO (ivacaftor), University of Washington-tested drug to treat the genetic…
Biotechnology | FDA | Oncology | Therapeutics
The U.S. FDA approved Erivedge (vismodegib) capsule, the first medicine for adults with advanced basal cell carcinoma
On Jan. 30, 2012, the U.S. Food and Drug Administration (FDA) approved Genentech’s Erivedge (vismodegib) capsule, the first…
The UC San Diego Health System acquired the Nevada Cancer Institute
On Jan. 23, 2012, UC San Diego Health System announced it had received approval to acquire the Nevada…
Rock and Roll Hall of Fame inductee Alice Cooper played a benefit concert at OMRF
On Jun. 24, 2012, Rock and Roll Hall of Fame inductee Alice Cooper helped raise $675,500 for the…
Renowned biochemist Michael A Marletta became president and CEO of The Scripps Research Institute
On Jan 1, 2012, renowned biochemist Michael A. Marletta became president and CEO of The Scripps Research Institute…
Alan Aderem, PhD, became president of Seattle BioMed – only the second in its more than 35-year history
On Jan. 1, 2012 Alan Aderem, Ph.D., became president of Seattle BioMed, now known as Center for Infectious…
Biotechnology | Diagnostics | Disease | NIH | Non-Profit Research | Oncology | Therapeutics | Veterinary
The UC Davis Comprehensive Cancer Center received NCI designation
In 2012, The UC Davis Comprehensive Cancer Center received NCI comprehensive cancer designation. The center is a matrix…
CALIBR, the California Institute for Biomedical Research, was founded
In 2012, CALIBR, the California Institute for Biomedical Research (Calibr), was launched as a nonprofit translational research institute…
Smilow Cancer Hospital and Yale Cancer Center opened 8 Smilow Cancer Care Centers in Connecticut
In 2012, Smilow Cancer Hospital and Yale Cancer Center opened 8 Smilow Cancer Care Centers in Connecticut. Today,…
Samantha Lewis at OSU won the Society for Molecular Biology and Evolution Undergraduate Diversity Mentoring Award
In 2012, Samantha Lewis, a senior in the Oregon State University College of Science, won the Society for…
The Basser Center for BRCA was established at Penn Medicine’s Abramson Cancer Center
In 2012, the Basser Center for BRCA was established at Penn Medicine’s Abramson Cancer Center to establish a…